Arm Announces Earnings Release Date for Second Quarter Fiscal Year Ending 2027

Arm Holdings plc (NASDAQ: ARM) will report financial results for the second quarter of fiscal year 2027 on Wednesday, Nov. 4, 2026, after market close. The company will host a conference call via audio webcast at 14:00 Pacific Time (17:00 Eastern Time / 22:00 Greenwich Mean Time) to review its financial results and business outlook.

The live audio webcast will be available at: https://edge.media-server.com/mmc/p/zyzi4u5w/ and a replay of the conference call can be accessed on http://investors.arm.com/ shortly afterwards. The replay will be available for four weeks.

About Arm

Arm is the foundational platform for AI, delivering power-efficient, high-performance computing that touches 100 percent of the connected global population. To meet the insatiable demand for compute, Arm's platform spans core IP, advanced compute subsystems and purpose-built silicon, giving the world's leading technology companies the flexibility to design, build and deploy AI at scale. Arm has the world's largest computing ecosystem, including over 22 million developers, and together we are building the future of AI on Arm.

All information is provided "as is" and without warranty or representation. This document may be shared freely, attributed and unmodified. Arm is a registered trademark of Arm Limited (or its subsidiaries or affiliates). All brands or product names are the property of their respective holders. © 1995-2026 Arm Limited.

Media
Kristen Ray
Kristen.Ray@arm.com

Investors
Arm Investor Relations
Investor.Relations@arm.com

News Provided by Business Wire via QuoteMedia

ARM
The Conversation (0)
Marvel Biosciences Reports MB-204 as Highly Effective at Treating Autism Behaviours in Shank3 Mouse Model

Marvel Biosciences Reports MB-204 as Highly Effective at Treating Autism Behaviours in Shank3 Mouse Model

Marvel Biosciences Corp. (TSXV: MRVL | OTCQB: MBCOF), and its wholly-owned subsidiary, Marvel Biotechnology Inc. (collectively the "Company" or "Marvel"), a drug discovery company developing novel therapeutics for autism spectrum disorder ("ASD") and related neurodevelopmental disorders, is... Keep Reading...
Miivo Completes Acquisition of First Five Partners

Miivo Completes Acquisition of First Five Partners

Miivo AI Inc. (TSXV: MIVO) (OTCQB: MIVOF) (FSE: L7S0) ("Miivo" or the "Company") is pleased to announce that it has completed its previously announced acquisition of 100% of the issued and outstanding shares of First Five Partners Sàrl ("First Five"), a Switzerland-based sports advisory,... Keep Reading...
Elton Resources

Elton Resources Now Trading on TSXV!

Elton Resources Corp. (TSXV: DBAY) (formerly, Chicane Capital I Corp.) (the "Company") is pleased to announce that the common shares of the Company (CUSIP 29035T302 / ISIN CA29035T3029) have commenced trading on the TSX Venture Exchange ("TSXV") under the symbol "DBAY" at market open on October... Keep Reading...
Apex Grants Option to Acquire a Mineral Claim

Apex Grants Option to Acquire a Mineral Claim

Apex Resources Inc. (TSXV: APX,OTC:SLMLF) (OTCID: SLMLF) ("Apex" or the "Company") announces that it has entered into an option agreement effective October 1, 2026 (the "Option Agreement") with ReOsiris Inc. ("ReOsiris"), an arm's-length party, pursuant to which ReOsiris has been granted the... Keep Reading...
MIIVO to Acquire First Five Partners, an AI Specialist in the Sports Sector

MIIVO to Acquire First Five Partners, an AI Specialist in the Sports Sector

Miivo AI Inc. (TSXV: MIVO,OTC:MIVOF) (OTCQB: MIVOF) (FSE: L7S0) ("Miivo" or the "Company") is pleased to announce that it has entered into a share purchase agreement dated September 29, 2026 (the "Agreement") to acquire 100% of the issued and outstanding shares of First Five Partners Sàrl... Keep Reading...

Interactive Chart

Latest Press Releases

Related News